GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo” or the “Company”), a company…
AndyJanuary 31, 2024
Application deadline is Feb. 15 for the pandemic network edition of “Make Your Medical Device Pitch for Kids!™ WASHINGTON, Jan.…
AndyJanuary 30, 2024
Johns Hopkins University has launched an ambitious endeavor that the school’s leaders say will make Baltimore a hub of the…
AndyJanuary 30, 2024
Florence, Jan. 26, 2024 – PQE Group, the renowned Life Science consulting powerhouse, concludes the fiscal year 2023 with a…
AndyJanuary 29, 2024
ROCKVILLE, Md., Jan. 29, 2024 /PRNewswire/ -- Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, today announced that it…
AndyJanuary 29, 2024
Germantown, Maryland, and State College, Pennsylvania, Jan. 25, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today…
adminJanuary 26, 2024
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
ROCKVILLE, Md., and SYDNEY, Australia, Jan. 23, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused…
AndyJanuary 23, 2024
After a period of leadership transition and strategic planning, the organizations behind one of Baltimore’s longest-standing entrepreneurial communities have appointed…
AndyJanuary 23, 2024
ARPA-H made its final hub location decision, selecting the historic Bowen Building in downtown Washington, D.C. as the site for…
AndyJanuary 23, 2024